CTI BioPharma is a biopharmaceutical company whose mission is to acquire, develop and bring to market less toxic, more effective therapies to treat and cure cancer. The company's therapeutic focus is on novel targeted therapies covering a spectrum of...Show all
Company (IPO / Went public)
Phone: 206-282-7100
3101 Western Avenue
Suite 800
Seattle, 98121
Washington, United States
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Oxygen linked pyrimidine derivatives | Jan 05, 2017 | Dec 31, 2019 | Patent |
11-2(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene citrate salt | Feb 13, 2015 | Apr 18, 2017 | Patent |
Oxygen linked pyrimidine derivatives | Feb 20, 2013 | Feb 21, 2017 | Patent |
Injectable pharmaceutical compositions of an anthracenedione derivative with anti-tumoral activity | Dec 10, 2010 | Dec 15, 2015 | Patent |
Peptide nucleic acid derivatives with good cell penetration and strong affinity for nucleic acid | Dec 19, 2013 | Nov 25, 2014 | Patent |